baber/WOPTO huggingface dataset:
Patent DE-69512524-T2 (DE)
Inventor: ADJEI DAVID
IPC: C07C303/36
Filed: 1995-07-21
Granted: 2000-05-04
Abstract: This invention relates to an improved method of making sulfonyl isocyanates from the corresponding sulfonamides and phosgene.
Patent DE-69516137-T2 (DE)
Inventor: BENOIT PIERRE
IPC: A63F9/08
Filed: 1995-05-24
Granted: 2000-08-24
Abstract: A corner element of a puzzle game that constitutes a three-dimensional pictorial representation of a building-like structure. The corner element comprises first and second backing members bonded to a flexible lithographic film. A hinge area separates the first and second backing members, allowing to bring them in a corner configuration by folding the lithographic film at the hinge area. The film has an exposed image-bearing surface constituting a pictorial entity that contributes to a complete representation of the building-like structure. The corner element is made from a blank that includes a layer of backing material laminated to the lithographic film. The backing material is die-cut at controlled depth to form the first and second backing members in a spaced apart relationship, separated by a waste strip. Prior to assembling the puzzle pieces, the user is required to peel off the waste strip from the blank in order to form the hinge area between the first and second backing members.
Patent DE-69518683-T2 (DE)
Inventor: BERTRAM RANDAL L
IPC: G06F3/038
Filed: 1995-03-06
Granted: 2001-08-02
Abstract: A computer system comprising a central processing unit (CPU) configured to accept coordinate type data from a touchpad or the like. The CPU has an operating system executing thereon with special support for interfacing to the touchpad. The operating system has the following capabilities: (1) mapping out geometric regions of the touchpad and assign the regions to specific region identifiers responsive to application programs and (2) determining the region identifier of a touched region and passing that region identifier to the application program. Support is also provided for changing the units of the commands used to define the regions. <IMAGE>   <IMAGE>   <IMAGE>
Patent DE-69523474-T2 (DE)
Inventor: ELMORE D
IPC: C09K23/00
Filed: 1995-12-20
Granted: 2002-05-16
Abstract: A novel epoxy-functional hydroxy ester composition is produced by reacting (a) dimethylolpropionic acid and (b) an aliphatic or cycloaliphatic glycidyl ether, an epoxy novolac or a cycloaliphatic epoxy having a functionality of at least about 1.5 epoxide group per molecule.
Patent DE-69608122-T2 (DE)
Inventor: FARRAR GRAHAM HENRY
IPC: A61K39/15
Filed: 1996-11-11
Granted: 2000-12-21
Abstract: A microparticle contains DNA coding for a non-immunogenic gene product and oral administration of the microparticle leads to its expression. DNA coding for a non-immunogenic gene product is for gene therapy applications. DNA is incorporated into the microparticle without destruction of its function. <IMAGE>
Patent DE-69612381-T2 (DE)
Inventor: RENARD ANDRE
IPC: A47F3/04
Filed: 1996-07-05
Granted: 2001-10-31
Abstract: PCT No. PCT/FR96/01055 Sec. 371 Date Dec. 31, 1997 Sec. 102(e) Date Dec. 31, 1997 PCT Filed Jul. 5, 1996 PCT Pub. No. WO97/01977 PCT Pub. Date Jan. 23, 1997The present invention relates to a refrigerated cabinet for displaying and/or conserving food products or the like, e.g. in a shop. A product display module (3) suitable for being mounted in easily removable manner on an air cooler module (2) includes cool air flow means, and at its bottom portion includes a pallet (4) having air guide means (53). The technical field of the invention is that of making refrigerated cabinets.
Patent DE-69614666-T2 (DE)
Inventor: BLIESZNER CLARE
IPC: A61K8/49
Filed: 1996-01-24
Granted: 2002-06-27
Abstract: Personal care compositions that are especially suitable for personal cleansing of the perineal area and protection against perineal dermatitis are disclosed. Preferred compositions include water, dimethicone, a polymeric emulsifier and optionally a water-soluble polyol, a pH-adjusting agent, an anti-microbial agent, and a chelating agent. Also disclosed are disposable wipe products containing a nonwoven or other substrate impregnated with the composition.
Patent DE-69618707-T2 (DE)
Inventor: MASUT LUCIO
IPC: B62M7/12
Filed: 1996-02-24
Granted: 2002-08-14
Abstract: A rear suspension arrangement for motor vehicles in which in a rear part of a motor vehicle frame (11) there are provided at least one engine (12) with relative carburettor (13), a drive shaft (23) with relative transmission unit (14), in the form of an arm, for transmitting rotation to a rear wheel (15), and at least one spring damper unit (16) located between the casing (17) of the arm of the transmission unit (14) and an overlying part (18) of the frame (11), wherein the engine (12), besides being connected by a pivot (19) to a central portion (20) of the frame (11), is also connected by a second pivot (21) to an overlying part (18) of the frame (11), the arm (14) containing the transmission being supported on and rockable about the drive shaft (23). <IMAGE>
Patent DE-69622599-T2 (DE)
Inventor: KAWATO JUNJI
IPC: A61K8/30
Filed: 1996-08-21
Granted: 2003-03-27
Abstract: PCT No. PCT/US96/13490 Sec. 371 Date Feb. 22, 1999 Sec. 102(e) Date Feb. 22, 1999 PCT Filed Aug. 21, 1996 PCT Pub. No. WO98/07406 PCT Pub. Date Feb. 26, 1998The present invention relates to a skin lightening composition comprising (a) a safe and effective amount of a compound of the formula (I)  wherein Z is Oxygen or Sulfur, (b) an average polarity solvent (c) a polyhydric alcohol (d) a solid fatty alcohol (e) a nonionic surfactant (f) water, and (g) lecithin wherein at least a portion of the above components (a), (b), (c), (d), (e), (f) and (g) forms a liquid crystal.
Patent DE-69627963-T2 (DE)
Inventor: PEARCE L BRUCE
IPC: A61K38/48
Filed: 1996-06-04
Granted: 2004-03-04
Abstract: The compositions and methods disclosed herein utilize admixtures of neurotoxins to cause denervation which is unexpectedly more localized and of longer duration than otherwise occurs with single neurotoxins. The compositions and methods of the invention utilize neurotoxin admixtures calibrated in median paralysis units rather than LD50s. Admixtures of neurotoxins include, but are not limited to, the botulinum serotypes A-G and tetanus toxin. The clinical benefits of the disclosed invention include: lengthening intervals between neurotoxin treatments; reducing adverse immunogenic responses to neurotoxins; and, reducing adverse diffusion-dependent side-effects of neurotoxin treatments.
Patent DE-69629439-T2 (DE)
Inventor: SHINJI TAI
IPC: C08G63/668
Filed: 1996-11-15
Granted: 2004-06-24
Abstract: Copolyesters consisting essentially of terephthalic acid units and ethylene glycol units, and further comprising 1 to 4 mole % of alicyclic or aliphatic bifunctional compound units (a1) or 0.5 to 7 mole % of bifunctional compound units (a2) derived from a specific aromatic diol or bifunctional compound units (a3) derived from a condensed ring or ring assembly type aromatic dicarboxylic acid, 0.005 to 1 mole % of multi-functional compound units (b1), and a specific amount of monofunctional compound units (c); copolyesters having a specific intrinsic viscosity and consisting essentially of terephthalic acid units and ethylene glycol units, and further comprising 0.5 to 7 mole % of the above bifunctional compound units (a2) and 0.005 to 1 mole % of specific multi-functional compound units (b2) or (b3); and copolyesters consisting essentially of terephthalic acid units and ethylene glycol units, and further comprising 0.5 to 7 mole % of the above bifunctional compound units (a3) and 0.005 to 0.5 mole % of the multi-functional compound units (b1). These copolyesters have excellent melt moldability, in particular extrusion blow moldability and give molded articles having excellent transparency, impact resistance, gelation characteristics, appearance, tactility, mechanical properties, heat resistance, chemical resistance and dimensional precision.
Patent DE-69635207-T2 (DE)
Inventor: LEVY-LAHAD EPHRAT
IPC: A61K38/17
Filed: 1996-07-05
Granted: 2006-06-22
Abstract: The present invention discloses nucleic acid molecules encoding AD4 gene products, expression vectors and host cells suitable for expressing such gene products. Also disclosed are methods for treating, preventing and diagnosing Alzheimer's Disease.
Patent DE-69635464-T2 (DE)
Inventor: ANAND JOGINDER N
IPC: C08K9/06
Filed: 1996-09-12
Granted: 2006-08-03
Abstract: Silicone rubber compositions are disclosed including a silicone polymer and a silicon-treated carbon black. The silicon-treated carbon blacks include a silicon-containing compound that is distributed through at least a portion of the carbon black aggregate. The silicon-treated carbon black is incorporated within a silicone rubber composition as an alternative reinforcing and extending filler, imparting higher hardness to elastomers formed from the composition, when compared to silicone rubber compositions incorporating an untreated carbon black.
Patent DE-69636213-T2 (DE)
Inventor: JACOBSEN STEPHEN C
IPC: A61M25/00
Filed: 1996-12-04
Granted: 2006-10-05
Abstract: A catheter guide wire includes a strip of material formed into an elongate coil, with a central hollow having a plurality of windings. The windings include inhibiting features to inhibit relative rotation of adjacent windings. A central wire core is inserted through the hollow of the coil and welded to some of the windings to keep them from separating longitudinally. This construction allows for lateral flexibility of the guide wire, but with desired torsional stiffness. <IMAGE>
Patent DE-69636339-T2 (DE)
Inventor: SUGIYAMA HARUO
IPC: A61K31/70
Filed: 1996-05-24
Granted: 2007-07-19
Abstract: A leukemic cell growth inhibitor containing antisense oligonucleotide derivatives against Wilms' tumor gene (WT1). <IMAGE>
Patent DE-69704644-T2 (DE)
Inventor: JACQUET ANDRE
IPC: B65G47/26
Filed: 1997-08-27
Granted: 2002-05-29
Abstract: The system of positioning and wedging of products (1) transported on a conveyor (10) comprises a pair of rollers (12,13) carried by a plinth (11) fixed to the conveyor. This pair of rollers engage a vertical element (3) of the product for its positioning and wedging. The product vertical element (3) is encastred between the two rollers of one pair of rollers. One of the rollers is of a hard material ensuring precise positioning. The other is of a flexible material ensuring support against the hard roller and compensating for possible variations in the side of the vertical elements.
Patent DE-69719367-T2 (DE)
Inventor: YAMAGATA YUTAKA
IPC: A61K9/16
Filed: 1997-12-18
Granted: 2003-10-16
Abstract: A method of producing sustained-release microcapsules which comprises dispersing a physiologically active polypeptide into a solution of a biodegradable polymer and zinc oxide in an organic solvent, followed by removing the organic solvent; which provides a sustained-release preparation showing a high entrapment ratio of the physiologically active polypeptide and its constant high blood concentration levels over a long period of time.
Patent DE-69721808-T2 (DE)
Inventor: PERKINS ANN
IPC: G01N21/55
Filed: 1997-11-05
Granted: 2004-01-29
Abstract: A surface plasmon resonance apparatus for detecting a soluble analyte (e.g. a protein) or a particulate analyte (e.g. a cell), the apparatus comprising: (a) a sensor block adapted to receive a sensor, said sensor, for example a sensor slide, having a metallised sensor surface capable of binding the analyte; (b) a light source capable of generating an evanescent wave at the sensor surface of a sensor slide on the sensor block; (c) a first detector capable of detecting light from the light source which is internally reflected from the sensor surface; and (d) a second detector (e.g. a video camera) capable of detecting light scattered or emitted from an analyte bound thereto. Optionally the apparatus further comprises a second light source for increasing the intensity of the light scattered or emitted from an analyte bound to the sensor surface, preferably this is sited to such as to minimise the amount of light transmitted therefrom which is detected by the first detector. Also disclosed are sensors adapted for use in the apparatus, and methods of detecting analytes in samples comprising exposing samples to the sensor surface of the apparatus.
Patent DE-69726309-T2 (DE)
Inventor: KOBAYASHI TOSHIAKI
IPC: C09K3/00
Filed: 1997-11-21
Granted: 2004-09-16
Abstract: The invention provides a gelling agent comprising at least one sugar compound selected from the group consisting of sugar compounds represented by the formula (1) and sugar compounds represented by the formula (2). <CHEM> wherein R<1> and R<2> are the same or different and each represents an alkyl group having 1 to 3 carbon atoms, an alkoxyl group having 1 to 3 carbon atoms or a halogen atom, and p is 0 or 1. The gelling agent of the invention is very useful as a gelling agent for an aqueous medium.
Patent DE-69733338-T2 (DE)
Inventor: GREGORY A
IPC: A61P29/00
Filed: 1997-02-11
Granted: 2006-03-16
Abstract: Use of a leukotriene B 4  receptor antagonist and a cyclooxygenase-2 inhibitor, 
wherein the cyclooxygenase-2 inhibitor is selected from compounds of Formula I:   
wherein A is pyrazolyl; 
wherein R 1  is at least one substituent selected from heterocyclo, cycloalkyl, cycloalkenyl and aryl, wherein R 1  is optionally substituted at a substitutable position with one or more radicals selected from alkyl, haloalkyl, cyano, carboxyl, alkoxycarbonyl, hydroxyl, hydroxyalkyl, haloalkoxy, amino, alkylamino, arylamino, nitro, alkoxyalkyl, alkylsulfinyl, halo, alkoxy and alkylthio; 
wherein R 2  is selected from alkyl and amino; and 
wherein R 3  is a radical selected from halo, alkyl, alkenyl, alkynyl, oxo, cyano, carboxyl, cyanoalkyl, heterocyclooxy, alkyloxy, alkylthio, alkylcarbonyl, cycloalkyl, aryl, haloalkyl, heterocyclo, cycloalkenyl, aralkyl, heterocycloalkyl, acyl, alkylthioalkyl, hydroxyalkyl, alkoxycarbonyl, arylcarbonyl, aralkylcarbonyl, aralkenyl, alkoxyalkyl, arylthioalkyl, aryloxyalkyl, aralkylthioalkyl, aralkoxyalkyl, alkoxyaralkoxyalkyl, alkoxycarbonylalkyl, aminocarbonyl, aminocarbonylalkyl, alkylaminocarbonyl, N-arylaminocarbonyl, N-alkyl-N-arylaminocarbonyl, alkylaminocarbonylalkyl, carboxyalkyl, alkylamino, N-arylamino, N-aralkylamino, N-alkyl-N-aralkylamino, N-alkyl-N-arylamino, aminoalkyl, alkylaminoalkyl, N-arylaminoalkyl, N-aralkylaminoalkyl, N-alkyl-N-aralkylaminoalkyl, N-alkyl-N-arylaminoalkyl, aryloxy, aralkoxy, arylthio, aralkylthio, alkylsulfinyl, alkylsulfonyl, aminosulfonyl, alkylaminosulfonyl, N-arylaminosulfonyl, arylsulfonyl, and N-alkyl-N-arylaminosulfonyl; 
  or a pharmaceutically-acceptable salt thereof, for preparing a medicament to suppress immune, acute or delayed-type hypersensitivity response in a subject.
Patent DE-69737035-T2 (DE)
Inventor: WATANABE MEIJI
IPC: C12N9/42
Filed: 1997-09-16
Granted: 2007-04-26
Abstract: A high-yield production system for proteins and peptides has been established, and especially a high-yield production system for cellulase in Trichoderma viride and similar filamentous fungi. The cellulase cbh1 gene regulator sequence derived from Trichoderma viride gives high expression of target proteins. The regulator sequence can therefore be used for high-yield expression of target proteins, especially cellulase. In particular, 15 g/L of an endoglucanase derived from Humicola insolens was successfully produced with this regulator sequence. <IMAGE>
Patent DE-69737884-T2 (DE)
Inventor: WALKER RANDALL C
IPC: G06F3/048
Filed: 1997-07-24
Granted: 2007-10-31
Abstract: A text enhancement method and apparatus for the presentation of text for improved human reading. The method includes extracting text specific attributes from machine readable text and varying the text presentation in accordance with the attributes. The preferred embodiment of the method: extracts parts of speech and punctuation from a sentence, applies folding rules which use the parts of speech to determine folding points, uses the folding points to divide the sentence into text segments, applies horizontal displacement rules to determine horizontal displacement for the text segments, and presents the text segments each on a new line and having the determined horizontal displacement. Another embodiment displays text color based on parts of speech.
Patent DE-69804918-T2 (DE)
Inventor: HODGEN GARY D
IPC: A61K31/57
Filed: 1998-06-15
Granted: 2002-11-07
Abstract: A method of female contraception involves administering a combination of estrogen and progestin for 60-110 consecutive days in which the daily amounts of estrogen and progestin are equivalent to about 5-35 mcg of ethinyl estradiol and about 0.025 to 10 mg of norethindrone acetate, respectively. The advantages include less menstrual bleeding, less patient anemia, less total exposure to medication, higher compliance rates and more lifestyle convenience for patients.
Patent DE-69805793-T2 (DE)
Inventor: JOWITT WILLIAM
IPC: B21D51/26
Filed: 1998-04-06
Granted: 2003-01-02
Abstract: Apparatus for a making can bodies comprises a reciprocating punch and a rotary turret (10) mounted for rotation about a horizontal axis parallel to the axis of the punch. A plurality of flexible finger sets (13) spaced circumferentially around the turret and extending generally radially from the turret are adapted to pick up, support and convey can bodies (16) stripped from the punch as the turret rotates. The turret is driven in rotation at a cyclically varying angular velocity such that the angularly velocity of finger set (13) is less at the moment when it engages a can body stripped from the punch than at other times.
Patent DE-69809525-T2 (DE)
Inventor: VELDHUIS NICOLAAS
IPC: G10L19/06
Filed: 1998-03-12
Granted: 2003-07-10
Abstract: Human speech is coded by singling out from a transfer function of the speech, all poles that are unrelated to any particular resonance of a human vocal tract model. All other poles are maintained. A glottal pulse related sequence is defined representing the singled out poles through an explicitation of the derivative of the glottal air flow. Speech is outputted by a filter based on combining the glottal pulse related sequence and a representation of a formant filter with a complex transfer function expressing all other poles. The glottal pulse sequence is modelled through further explicitly expressible generation parameters. In particular, a non-zero decaying return phase supplemented to the glottal-pulse response that is explicitized in all its parameters, while amending the overall response in accordance with volumetric continuity.
Patent DE-69811565-T2 (DE)
Inventor: GELLERT JOBST ULRICH
IPC: B22D17/20
Filed: 1998-05-18
Granted: 2003-07-10
Abstract: Apparatus for stack injection molding wherein a melt distribution manifold (36) is mounted between two manifold retainer plates (10,50). A number of heated nozzles (16) are seated in each plate (10,50) with the nozzles in one plate (10) extending in an opposite direction to the nozzles in the other plate (50). The nozzles (16) in the one plate (10) are held in place by the manifold (36) being secured to that plate (10). The nozzles (16) in the other plate (50) each have retaining apparatus (54) to hold them in place during assembly and disassembly. Each nozzle retaining apparatus (54) has a main body (56) with a screw opening (58) therethrough and an elongated pin (60) extending laterally therefrom. The pin (60) extends into a hole (64) in the nozzle (16) and a screw (62) extending through the screw opening (58) in the main body (56) is tightened into a hole (68) in the manifold retainer plate (50) to secure the nozzle (16) in place during assembly and disassembly of the manifold retainer plates (10,50). <IMAGE>
Patent DE-69813203-T2 (DE)
Inventor: WITSENBOER HANNEKE
IPC: C12Q1/6853
Filed: 1998-07-21
Granted: 2004-02-12
Abstract: The invention relates to the use in selective restriction fragment amplification (AFLP), of a primer that contains one or more alternative nucleosides. The primer preferably contains 2-10, preferably 4-8, selective nucleotides, and less than three, more preferably less than two, more preferably only one alternative nucleoside(s). The alternative nucleosides are preferably present in a position 1-10 bases, preferably 2-8 bases, more preferably 4-7 bases from the 3'-end of the primer sequence; and/or are preferably in the variable region of the primer sequence or the first four base positions adjacent thereto. Preferred alternative nucleosides comprise an alteration in the purine or pyrimidine base nucleus, the sugar residue, the bond between the base nucleus and the sugar residu, and/or its bond to other nucleosides present in the primer sequence, compared to the naturally occurring nucleosides A, T, C and G. The primers may also comprise a peptide nucleic acid. <IMAGE>
Patent DE-69819798-T2 (DE)
Inventor: TZIMAS MICHAEL
IPC: B01J31/06
Filed: 1998-03-16
Granted: 2004-09-23
Abstract: A process for the chlorination of an aromatic compound of the following formula (A) : <CHEM> wherein R<A> is H or C1 to C12 alkyl, cycloalkyl, aryl, alkaryl, aralkyl or carboxyalkyl, the or each R<B> is selected from H, C1-C4 alkyl (especially methyl), C1-C4 haloalkyl or polyhaloalkyl, e.g. C1-C4 perfluoroalkyl, C1-C4 alkoxy, C5-C12 aryl (e.g. phenyl), alkaryl or aralkyl, or halogen, and n is an integer which is 0, 1 or 2, and the or each R<B>, if present, may independently be attached at the ortho or the meta position (preferably at the meta position), which process comprises reacting (preferably in heterogeneous liquid/solid phase below 35 DEG C) the aromatic compound (which is preferably phenol) with a chlorinating agent (preferably sulphuryl chloride) in the presence of a sulphur-containing catalyst, optionally also in the presence of a Lewis acid co-catalyst, characterised in that the sulphur-containing catalyst is an organic compound according to the following formula (I) or formula (II) : <CHEM>  in which:   PS represents a polymeric backbone preferably selected from polystyrene or a polysiloxane, e.g. a polyalkylsiloxane or a polyalkylarylsiloxane;   x is an integer which is 0 or from 1 to 12; R<1>, R<2>, R<3> and R<4> are each independently selected from the group consisting of: optionally substituted straight or branched chain alkyl or alkanediyl having from 1 to 20 (preferably 1 to 10) carbon atoms, optionally substituted straight or branched chain alkaryl or aralkyl having from 5 to 20 carbon atoms, and optionally substituted aryl having from 5 to 20 carbon atoms; X<1> and X<2> are each independently selected from the group consisting of halogen (preferably Cl, Br or I), thiol, dialkylsulphonium halide and R5, where R5 is selected from the group consisting of: optionally substituted straight or branched chain alkyl or alkanediyl having from 1 to 20 (preferably 1 to 10) carbon atoms, optionally substituted straight or branched chain alkaryl or arallkyl having from 5 to 20 carbon atoms, and optionally substituted aryl having from 5 to 20 carbon atoms; y is a number (which may be integral or non-integral) greater than zero, preferably up to about 10000, more preferably in the range from about 1 to about 1000, particularly from about 1 to about 500 and especially from about 2 to about 100; wherein in the above definitions of R<1>, R<2>, R<3>, R<4> and R<5> the optional substituents may be independently selected from the following: halogen (e.g. F, Cl), hydroxy, amino, cyano, nitro, C1-C4 alkyl, C1-C4 haloalkyl e.g. C1-C4 perfluoroalkyl, C1-C4 alkoxy, C1-C4 alkoxycarbonyl.